Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.33 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8947031 | 1.00 | TSHR (0.41) | TSHRCYP3A4TDP1PKMSMN1; SMN2 | |
| SCHEMBL20819805 | 0.85 | TSHR (0.46) | TSHRCYP3A4TDP1PKMSMN1; SMN2 | |
| SCHEMBL20819807 | 0.84 | MEN1 (0.36) | TSHRTDP1ALDH1A1HSD17B10 | |
| SCHEMBL5710506 | 0.79 | TDP1 (0.37) | TSHRCYP3A4TDP1MAPTCACNA1B | |
| SCHEMBL2144022 | 0.79 | TSHR (0.40) | TSHRCYP3A4TDP1PKMSMN1; SMN2 | |
| SCHEMBL465993 | 0.78 | TSHR (0.40) | TSHRCYP3A4TDP1PKMSMN1; SMN2 | |
| SCHEMBL1024005 | 0.78 | TSHR (0.40) | TSHRCYP3A4TDP1PKMSMN1; SMN2 | |
| SCHEMBL222774 | 0.77 | ALDH1A1 (0.46) | TSHRTDP1PKMMAPTALDH1A1 | |
| SCHEMBL126032 | 0.77 | ALDH1A1 (0.46) | TSHRTDP1PKMMAPTALDH1A1 | |
| SCHEMBL3762398 | 0.77 | HPGD (0.31) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260139101-A1 | ACRYLIC COMPOUND CONTAINING FLUOROPOLYETHER GROUP, ACTINIC-RAY-CURABLE COMPOSITION, CURED COATING FILM FORMED FROM SAID CURABLE COMPOSITION, AND ARTICLE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-05-21 | — | — | US | disclosed |
| EP-4600289-A1 | ACRYLIC COMPOUND CONTAINING FLUOROPOLYETHER GROUP, ACTINIC-RAY-CURABLE COMPOSITION, CURED COATING FILM FORMED FROM SAID CURABLE COMPOSITION, AND ARTICLE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-08-13 | — | — | EP | disclosed |
| EP-3642284-B1 | CURABLE ORGANOPOLYSILOXANE COMPOSITIONS | WACKER CHEMIE AG (DE) | 2022-06-01 | — | — | EP | disclosed |
| US-9496468-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2016-11-15 | — | — | US | disclosed |
| US-9178120-B2 | Curable resin composition, curable resin composition tablet, molded body, semiconductor package, semiconductor component and light emitting diode | KANEKA CORPORATION (JP) | 2015-11-03 | — | — | US | disclosed |
| US-20150188008-A1 | CURABLE RESIN COMPOSITION, CURABLE RESIN COMPOSITION TABLET, MOLDED BODY, SEMICONDUCTOR PACKAGE, SEMICONDUCTOR COMPONENT AND LIGHT EMITTING DIODE | KANEKA CORPORATION (JP) | 2015-07-02 | — | — | US | disclosed |
| US-20130082369-A1 | CURABLE RESIN COMPOSITION, CURABLE RESIN COMPOSITION TABLET, MOLDED BODY, SEMICONDUCTOR PACKAGE, SEMICONDUCTOR COMPONENT AND LIGHT EMITTING DIODE | KANEKA CORPORATION (JP) | 2013-04-04 | — | — | US | disclosed |
| EP-1284979-B1 | PREPOLYMERIC (METH)ACRYLATES WITH POLYCYCLIC OR AROMATIC SEGMENTS | 3M ESPE AG (DE) | 2004-12-29 | — | — | EP | disclosed |
| EP-1202997-B1 | HYDROLYZABLE SILANES AND POLYMERIZABLE SILANES WITH LOW VISCOSITY AND USE THEREOF | 3M ESPE AG (DE) | 2003-09-17 | — | — | EP | disclosed |
| EP-1284979-A1 | PREPOLYMERIC (METH)ACRYLATES WITH POLYCYCLIC OR AROMATIC SEGMENTS | 3M Espe AG (DE) | 2003-02-26 | — | — | EP | disclosed |
| EP-1202997-A1 | HYDROLYZABLE SILANES AND POLYMERIZABLE SILANES WITH LOW VISCOSITY AND USE THEREOF | 3M Espe AG (DE) | 2002-05-08 | — | — | EP | disclosed |
| WO-2001092271-A1 | PREPOLYMERIC (METH)ACRYLATES WITH POLYCYCLIC OR AROMATIC SEGMENTS | 3M ESPE AG (DE) | 2001-12-06 | — | — | WO | disclosed |
| WO-2001007444-A1 | HYDROLYZABLE SILANES AND POLYMERIZABLE SILANES WITH LOW VISCOSITY AND USE THEREOF | 3M ESPE AG (DE) | 2001-02-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139101-A1 | ACRYLIC COMPOUND CONTAINING FLUOROPOLYETHER GROUP, ACTINIC-RAY-CURABLE COMPOSITION, CURED COATING FILM FORMED FROM SAID CURABLE COMPOSITION, AND ARTICLE | RAD51, F11, AFF1 | TSHR 2717/4885CYP3A4 4439/4885TDP1 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.